EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Company News
Home
>
Newsroom
>
Company News
ALL
2025
2024
2023
2022
2021
2020
2019
2018
2016
2015
2014
2013
2012
2007
2025.02.24
CanSinoBIO Obtained Approval for Clinical Trials on DTcP-Hib-MCV4 Combined Vaccine
2025.02.07
CanSinoBIO Announces Priority Review Status for DTcP Infant
2025.02.06
CanSinoBIO Obtained Halal Decree of Menhycia® in Indonesia
2025.02.06
CanSinoBIO Received Acceptance of New Drug Application for its Tetanus Vaccine
1